chrisvoncsefalvay/vaers-outcomes huggingface dataset:
swollen lymph node on collar bone of the left side of the injection; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swollen lymph node on collar bone of the left side of the injection) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced LYMPHADENOPATHY (swollen lymph node on collar bone of the left side of the injection). At the time of the report, LYMPHADENOPATHY (swollen lymph node on collar bone of the left side of the injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication included Ibuprofen. No relevant concomitant medications were reported.
Yesterday morning, left leg was reddened and the size of quarter. Last night size of a golf ball and this morning her leg was red and size of a canned coke. Applied ice for 5 minutes by mother.
Information regarding PREVNAR 7 was received from a consumer regarding a 6-month-old male patient who experienced fever, breathing issues and rash. The patient received a dose on 12-Feb-2010. The patient experienced fever, breathing issues and rash on 12-Feb-2010. No additional information was available at the time of this report.
after eating breakfast which included his routine fair of toast with jam and sunflower seed butter, he started throwing up and his lip started to swell. He had been eating sunflower seed butter for many months before that and he had no problems with it before. But just a few days after the immunizations he had a new Anaphylactic allergy to sunflower seeds. He had five (5) Immunization shots on Monday (Polio, DTP: [Diphtheria, Tetanus, Pertussis], Chicken Pox, Measles, Mumps, Ruebella) all in one day on May 11, 2009.
Hep B Vaccine administered on 07/15/2019 was invalid as it expired on 07/03/2019. No Adverse Reaction occurred.
A consumer reported that he received an injection of Flu Shield '00-'01 on 12/14/00 and subsequently developed pain in the shoulder area of his left arm and can not raise his arm.
Case previously recorded as MA2009-4595. Received the following via Medical Communications (MedCom) from a healthcare professional on 18 NOV 2009: 3 year and 9 month old child was vaccinated with S-OIV FLUVIRIN (batch number 1013263P) on 18 NOV 2009. Administration of S-OIV FLUVIRIN to a child younger than 4 is not recommended/licensed. No adverse events have been reported. MedCom ref. no.: NA09-008487.
I administered adult dose 1.0 mL of Hep A vaccine when it should have been 0.5 mL - Dose for adolescent. Missed Admin. Patient tolerated injection well.
First one was 45 mins after injection. - Numbness of the left side of my face.  The next day was tired and slept most of the day.  This was the same as my first shot.  Tuesday, I woke up with a stomach ache.  Thursday  because it did not get better, I went to the emergency room and was diagnosed with pancreatitis.  Was given the option to be hospitalized or go home.  I went home.  Followed up with Dr's office Monday.  I see GI Doctor this Wednesday.  Still cannot eat, nauseous and stomach hurts.
Received immunizations for kindergarten. One and half days later the site of injection began to welt, was hot, and painful for patient to walk. Very uncomfortable. Reached out to triage center with concerns. Sent photos to triage center. They informed me they would contact the provider (urgently). Called me to inform me that the patient is experiencing ?local reaction?  and will need to put cold compress 4x a day, 7.5ml ibuprofen for pain/inflammation, and 7.5ml Benadryl for itching.
Information has been received from a physician concerning a 46 year old female patient with not pertinent medical history and not drug reaction or allergies who on 02-AUG-2010 was vaccinated intramuscularly with a dose of MMR II (Lot # 666510/1624Y). There was no concomitant medication. On 02-NOV-2010 the patient experienced maculopapular pruritic rash "from head to toe" and fever of 101.5. At the time of the report, the patient had not recovered. The patient sought unspecified medical attention. No further information is available.
Information has been received from a certified medical assistant concerning an 80 year old female with hypertension who on 13-MAR-2007 was vaccinated with a dose of Pneumovax 23 (lot #655152/0889F), 0.5 ml, IM.  Concomitant therapy included alendronate sodium (MSD) and MICARDIS.  On 14-MAR-2007, the patient experienced redness in the arm in which she was vaccinated (which arm was unspecified).  The patient was treated with topical hydrocortisone and TYLENOL.  The outcome and causality of the event was not reported.  Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a female patient, age reported as "60". She had none pertinent medical history and no drug reactions or allergies on file. On 03-JUL-2014 the patient was vaccinated with a dose of ZOSTAVAX, 0.65 ml in the left deltoid; route not specified, expiration date 06-MAR-2015, lot# reported as K000995M. On 05-JUL-2014, the patient developed a rash that looked like shingles surrounding the vaccination site. The patient reported no other symptoms to the reporting pharmacist. There was no treatment provided and no lab diagnostic studies were performed. The patient sought medical attention and had an appointment with her primary physician scheduled, however, expressed concerns about seeing the physician because of physician's pregnancy. The outcome of the adverse event was unknown. Relatedness between use of ZOSTAVAX and the adverse event was not reported. Lot number K000995M is an invalid lot number for ZOSTAVAX. Additional information has been requested.
fever 104.7 on 6JUL93 & 7JUL93 & temp cont for 1 wk; immun given 6JUL93 seen by MD 9JUL93 & again on 11JUL93 was presc advil & trimeth-sulfa;
Within 10 minutes, sensation of very cold skin through out my body, lasted 4 hours. Transient elevated systolic BP, better within 30 mins. Also mild body itching, still having.  Woke up this morning, ~24 hours post- injection with sever joint and muscle aches, chills etc.  had to cancel work.
Two days after vaccination, arm became very painful and she was unable to lift it without severe pain. Denied redness but states she had a large knot. Severe pain came and went over next several days, was reported to radiating to joint. Employee was instructed to go to physician for follow - Pain continued for 3 weeks moderate to severe and patient also reported some redness and slight swelling, continuing treatment at this time.
Used Pfizer Orange cap undiluted vaccine for an adult resulting in lower than expected dosage.  Patient recalled and adult dose of Pfizer Grey cap administered
About one hour after receiving the vaccine, I realized that I had a probable floater in my left eye. I have never had a floater before in my life. I decided it was a floater after describing the symptom to my wife, who does have floaters.
This spontaneous report as received from a registered nurse refers to  an unspecified number of patients of unknown age and genders. The patient's medical history was not reported. On an unknown dates the patient were vaccinated with improperly stored doses of GARDASIL (route and dosage unknown; lot # reported as M009378, EXP 23-APR-2018). No adverse event was reported. This is one of several reports from the same reporter. Lot number M009378 is an invalid lot number for GARDASIL. Additional information has been requested.
Immediately started shaking both arms, arms were rigid. Body went backwards in chair; the chair fell back. Child hit head against window frame. Nurses assistant helped into a kneeling position. He was confused and dazed for about 2 minutes. The pt was pale. The pt was taken to ER. Dx is fainting.
Patient got red flushing/rash all over chest after vaccine. She was given 25mg of diphenhydramine and felt better shortly after.
whole body was itchy; injection site hot; injection site swollen; injection site red; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (whole body was itchy), VACCINATION SITE WARMTH (injection site hot), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (injection site red) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (whole body was itchy), VACCINATION SITE WARMTH (injection site hot), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (injection site red). At the time of the report, PRURITUS (whole body was itchy), VACCINATION SITE WARMTH (injection site hot), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (injection site red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: No newinformation
Patient appeared nervous prior to vaccination and was fine immediately following vaccine. After her 15 minute observation, she stood up from a chair and passed out and fell onto the floor. She regained consciousness after a few seconds and said she had felt dizzy and had felt like "she was sleepwalking" before the fell. Patient never had trouble breathing/swallowing. Patient's mother had mentioned she had a similar reaction after the got a Novocain shot in the dentist office. Another patient had called 911 and the EMS squad came and assessed her and took her to the emergency department from the pharmacy.
Approximately 3 hours after receiving vaccine (Tdap) employee awoke from a nap, experiencing migraine headache, general malaise, chills, temp of 100.7, nausea. Lingering H/A following day accompanied with swollen fingers on right hand and a "grapefruit" size induration on right deltoid at site of injection. This lasted for 10 days, along with pain at the site. Right wrist pain developed and has continued to present. Employee helped by wearing supportive brace. Generalized muscle aches persisted 5-6 days after injection.
was feeling lightheaded, sweaty, heart racing, paleness, weakness within 20 minutes of receiving high dose flu vaccine. Brought to the pharmacy room. 11:50am her blood pressure 140/80, pulse was 83-88, O2 sat 100%. 12:50pm pulse 83 BP 110/70, O2 sat 100%. She continuously felt shaky and had a dry mouth. We continually asked if she had any trouble breathing or if she was feeling itchy. Injection site looked normal. At 1:12pm she was able to walk and didn't feel weak. Took her to her car in wheelchair. Her sister was there and she is going to keep an eye on her for the rest of the day.
Rash on left leg 24 hours after immunization that was the size of a quarter.
I stopped experiencing this many weeks ago; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (I stopped experiencing this many weeks ago) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (I stopped experiencing this many weeks ago). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (I stopped experiencing this many weeks ago) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 18-Jun-2021 and was forwarded to Moderna on 18-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (I stopped experiencing this many weeks ago) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO Medical History Information was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (I stopped experiencing this many weeks ago). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (I stopped experiencing this many weeks ago) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Within 3 hours, my throat swelled up and hurt; I could not swallow; my ears hurt; mucus developed at the back of my throat; I threw up in the ER; the symptoms began to subside after 4 hours in the ER.
A report has been received from a Health Professional concerning a 4 year old, Female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST started on 17-Dec-2013. The office manager reported that on 17-Dec-2013, they accidentally gave expired FLUMIST to two patients. Neither patient had reported any symptoms. The outcome of the event of expired FLUMIST administered is unknown. The report was considered to be non-serious by reporter.
She said her arm starting hurting right after the shot. Very sore. She same by pharmacy today, said it hurts to even lift her arm. She said it hurts constantly. No redness or swelling at the site of where the shot was given. She said she is going to see her primary MD about it tomorrow (10/24/18). I told her to please call me and tell me what they say.
On Friday, 1/29, after receiving the vaccine, I experience a headache, sharp right side pain in my neck, jaw, and ear.  On Saturday, 1/30, I woke up, and the right side of my face was numb, and my right eye would not blink.   I went to ER.  When they took my vitals, I had high blood pressure and fever.  They did a CT scan of my head and admitted me.  I was diagnosed with Bell's Palsy.  I was discharged on Sunday, 1/31, with medications:  Valacyclovir 1 gram three times a day and Prednisone 20 mg three times a day.  I was instructed to followup with a neurologist, immunologist, ophthalmologist, and my primary care physician.
I82.409 ACUTE DVT, UNSPECIFIED VEIN 4/18/2023 ACUTE DVT, UNSPECIFIED VEIN I82.409 ACUTE DVT, UNSPECIFIED VEIN 4/18/2023 ACUTE DVT, UNSPECIFIED VEIN I82.409 ACUTE DVT, UNSPECIFIED VEIN 4/18/2023 ACUTE DVT, UNSPECIFIED VEIN
administered to a client today which is greater than 12 hours later; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered to a client today which is greater than 12 hours later) in a 22-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered to a client today which is greater than 12 hours later). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered to a client today which is greater than 12 hours later) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
Pt recv vax 16OCT97 & the next day pt exp SOB, nausea, chills, sweats, h/a, dizziness, stiff neck, general myalgia & malaise;sx have occurred w/increasing severity p/each vax; It was reported that a 34-year-old female was vaccinated with RAB-IMOVAX Rabies on October 16, 1997 as the fourth dose of a post exposure treatment series. The next day the patient experienced shortness of breath, nausea, chills, sweats, headache, dizziness, stiff neck, general nyalgia and malaise. The patient has been in contact with her physician regarding these symptoms. The patient reports that the symptoms have occurred with increasing severity following each vaccine dose of the treatment series. From follow-up #1, November 7, 1997, the recovery status of the patient was not reported and remains unknown. From Follow-up correspondence received at Manufacturer on 18-Apr-2000, it was reported that the patient recovered from this experience. The patient had paranoid schizophrenia and this impairs comunication at times, she had recovered from bite and reaction.
Received ZOSTAVAX (shingles vaccine) on 8/13/09 at 4PM, noticed rash to (L) shoulder, (L) neck area on 8/18/09 with head & eye sensitivity. Pt called after visiting his physician. No recommendations, medications, run its course.
This spontaneous report as received from a Registered Nurse refers to a 40 week old patient. The patient's medical history and current condition are not reported. It was reported that a 40 weeks old infant was administered dose 3 of ROTATEQ on 29-JUL-2014. No adverse events were reported. Also reported that there is no product quality complaint. The outcome of the events is unknown. Additional information has been requested.
Extreme pain, redness, and swelling in the arm at the injection site. Fever of 101 degrees. She went to her MD office who diagnosed her with cellulitis and put her on Cephalexin 500mg for 10 days.
Pt called clinic reporting SOB, throat feels funny.  Instructed to go to ER.  At ER, patient did well and left with BENADRYL.  There was some confusion of symptoms related to new use of Niacin but symptoms did not recur.
Pt lost consiousness in chair & staff brought patient to floor. C/O dizziness & fast heart rate. Was nervous & doesn't like needles. BP 102/54; HR 69; RR 18. Pt was provided water; laid in supine position w/extremities lifted. Chest stable & conscious. Alert & able to verbalize name & location. Monitored for 30 minutes. Informed to seek medical attention if sx start again.
This case was reported by a consumer via call center representative and described the occurrence of disorientation in a male patient who received SHINGRIX for prophylaxis. On 31st August 2018, the patient received the 1st dose of SHINGRIX. On 31st August 2018, less than a day after receiving SHINGRIX, the patient experienced disorientation, light headedness, injection site pain, pain in arm and weird feeling. On an unknown date, the outcome of the disorientation, light headedness, injection site pain, pain in arm and weird feeling were unknown. It was unknown if the reporter considered the disorientation, light headedness, injection site pain, pain in arm and weird feeling to be related to SHINGRIX. Additional details were provided as follows: This case was reported by the patient's wife. The age at vaccination was not reported. The patient felt very odd (light headed, disoriented and extreme pain at the injection site for the entire day). The patient's arms were very sore much longer. The reporter asked would the side effects be as severe with the second dose. This case has been linked with US2018GSK175244, reported by the same reporter.
Pt recvd flu vax & was 1 of 15 pts who devel influenza & was hospitalized;
Follow-up information was received that provided source information patient information, vaccination information, concomitant vaccines, additional events and outcome. Information regarding PREVNAR was received from a healthcare professional regarding a patient who experienced rash all over body, fussiness, red swollen feet, and loose bowel movements. The patient received the first dose on 20-Jan-2009. The patient also received a dose of PENTACEL (Aventis-Pasteur), a dose of ROTATEQ (Merck & Co Inc)  and a dose of Hepatitis B Vaccine (manufacturer unknown) on 20-Jan-2009. On 25-Jan-2009, the patient developed rash all over body, red swollen feet and loose bowel movements and was fussy. The patient recovered. No additional information was available at at the time of this report.
High fever of 102.  A day later (9-24-2015) he had the onset of a measle-like rash on neck (front and back) and on tummy.  The day after that (9-25-2015) the rash covered the trunk and torso and was spreading to arms, legs, and face.  The fever continued, but did go down with Tylenol and ibuprofen.  The highest temp was 103.4.  On 9-25-2015, the patient started refusing to eat at around 12:00 PM.
NO ADVERSE REACTION AT THIS TIME.  CONTACTED doctor OFFICE. DUPLICATION OF VACCINATION GIVEN, ONE IN EACH ARM.  COUNSELLED ACCORDINGLY.
The client received a pooled dose of Pfizer Gray cap (12 and older) for his second primary series. The clinic was provided at an off site clinic. The RN whom had drawn the dose had pooled two vials of Pfizer Gray Cap (12 and older) lot# FK9894 together to achieve extra dose of vaccine. Lead RN reported the medication error to her supervisor whom sought guidance from the CDC. The CDC reported back and confirmed the dose as valid.  The ruling decision was made on 05/01/2022.
Can not move arm at all without help. Can not touch it or move it without being in excruciating pain. Nausea. Light headed.
Hives, itchy-started from abdomen and spread all over the body next day. I took BENADRYL @ 8 PM 10/26/09. Symptoms worse 10/27/09.
Lethargy, feeling foggy Narrative: Patient reports receiving her 2nd Covid vaccine 2 days prior and then stated she feels "wires are crossed". Patient reports feeling foggy and having loose stools 4-5 times per day. Patient denies any reaction to previous Covid vaccine. Patient denies any fever/temp/chills, abd pain, chest pain wheezing or sob.
Initial report received on 03 October 2007 from another manufacturer, report number not provided. The initial reporter to this manufacturer had been a health care professional. A patient (age and gender not specified) had received an injection of Menomune A/C/Y/W-135, lot number not reported, route and site of administration not reported, on an unspecified date approximately four to five years ago. On an unspecified date post-vaccination, the patient developed a Stevens Johnson reaction. Additional information was not provided.